Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-05-030571
Filing Date
2005-10-03
Accepted
2005-10-03 09:13:46
Documents
1
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 v025977_6k.htm 6-K 35038
  Complete submission text file 0001144204-05-030571.txt   36356
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 051115766
SIC: 2834 Pharmaceutical Preparations